Nā Huahana a me nā Hoʻonā a Macro & Micro-Test

PCR Fluorescence | Hoʻonui Isothermal | Chromatography Colloidal Gold | Immunochromatography Fluorescence

Nā huahana

  • 11 ʻAno o ka maʻi hanu

    11 ʻAno o ka maʻi hanu

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā maʻi hanu maʻamau i loko o ka sputum kanaka ma ke ʻano in vitro, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonas maltophilia (Smet), Bordetella pertussis (BP), Bacillus parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi i hoʻopaʻa ʻia ma ka haukapila a i ʻole nā ​​maʻi koʻikoʻi me nā maʻi bacteria i manaʻo ʻia o ka ʻōpū hanu.Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā maʻi hanu maʻamau i loko o ka sputum kanaka ma ke ʻano in vitro, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonas maltophilia (Smet), Bordetella pertussis (BP), Bacillus parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi i hoʻopaʻa ʻia ma ka haukapila a i ʻole nā ​​maʻi koʻikoʻi me nā maʻi bacteria i manaʻo ʻia o ka ʻōpū hanu.

  • Ka Hoʻololi ʻana o ka Gene Fusion PML-RARA kanaka

    Ka Hoʻololi ʻana o ka Gene Fusion PML-RARA kanaka

    Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka PML-RARA fusion gene i loko o nā hāpana iwi kanaka in vitro.

  • 14 ʻAno o nā pathogens hanu i hui pū ʻia

    14 ʻAno o nā pathogens hanu i hui pū ʻia

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.

  • Orientia tsutsugamushi

    Orientia tsutsugamushi

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka nucleic acid o Orientia tsutsugamushi i loko o nā laʻana serum.

  • ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin (RIF), Resistance (INH)

    ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin (RIF), Resistance (INH)

    Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka DNA Mycobacterium tuberculosis in vitro i loko o ka sputum kanaka, ka moʻomeheu paʻa (LJ Medium) a me ka moʻomeheu wai (MGIT Medium), ka wai lavage bronchial, a me nā mutations ma ka ʻāpana codon amino acid 507-533 (81bp, rifampicin resistance determing region) o ka gene rpoB o Mycobacterium tuberculosis rifampicin resistance, a me nā mutations ma nā wahi mutation nui o Mycobacterium tuberculosis isoniazid resistance. Hāʻawi ia i ke kōkua i ka ʻike ʻana i ka maʻi Mycobacterium tuberculosis, a ʻike ia i nā genes pale nui o rifampicin a me isoniazid, e kōkua ana i ka hoʻomaopopo ʻana i ke kūʻē ʻana o ka lāʻau lapaʻau o Mycobacterium tuberculosis i loaʻa i ka maʻi.

  • ʻAno Poliovirus Ⅲ

    ʻAno Poliovirus Ⅲ

    He kūpono kēia pahu hana no ka ʻike ʻana i ka Poliovirus Type Ⅲ nucleic acid i loko o nā hāpana ʻōpala kanaka ma vitro.

  • ʻAno Poliovirus Ⅰ

    ʻAno Poliovirus Ⅰ

    He kūpono kēia pahu hana no ka ʻike ʻana i ka poliovirus type I nucleic acid i loko o nā hāpana lepo kanaka ma vitro.

  • ʻAno Poliovirus II

    ʻAno Poliovirus II

    He kūpono kēia pahu hana no ka ʻike ʻana i ka Poliovirus Type Ⅱnucleic acid i loko o nā hāpana ʻōpala kanaka ma vitro.

  • ʻO ka maʻi Enterovirus 71 (EV71)

    ʻO ka maʻi Enterovirus 71 (EV71)

    Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka enterovirus 71 (EV71) nucleic acid in vitro i loko o nā swabs oropharyngeal a me nā laʻana wai herpes o nā maʻi me ka maʻi lima-wāwae-waha.

  • ʻO Enterovirus Universal

    ʻO Enterovirus Universal

    Ua manaʻo ʻia kēia huahana no ka ʻike ʻana i nā enteroviruses in vitro i loko o nā swabs oropharyngeal a me nā hāpana wai herpes. ʻO kēia pahu hana no ke kōkua ʻana i ka ʻike ʻana i ka maʻi lima-wāwae-waha.

  • Pahu ʻike ʻana i ka waikawa nucleic herpes simplex type 1 (Fluorescence PCR)

    Pahu ʻike ʻana i ka waikawa nucleic herpes simplex type 1 (Fluorescence PCR)

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi Herpes Simplex Type 1 (HSV1).

  • ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis Nucleic Acid Detection Kit (Fluorescence PCR)

    ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis Nucleic Acid Detection Kit (Fluorescence PCR)

    Ua manaʻo ʻia ka pahu hana no ka ʻike ʻana i ka qualitative in vitro o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG)a meʻO ka Trichomonal vaginitis (TV) i loko o ka swab urethral kāne, ka swab cervical wahine, a me nā laʻana swab vaginal wahine, a hāʻawi i ke kōkua i ka ʻike ʻana a me ka mālama ʻana i nā maʻi me nā maʻi genitourinary tract.